Skip to main content

Prometheus Biosciences, Inc.

RXDXDelisted Jun 16, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001718852

Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Prometheus Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

RXDX is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023

Institutional holders
2
−217 vs. Q1 2023
Shares held
18.5K
−40.5M (−100.0%) vs. Q1 2023
Total value
$1.98M
−$4.35B (−100.0%) vs. Q1 2023
New holders
0
0 more added
Sold out
217
0 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 2 institutions
Q1 2021: 41 institutionsQ2 2021: 49 institutionsQ3 2021: 51 institutionsQ4 2021: 74 institutionsQ1 2022: 103 institutionsQ2 2022: 116 institutionsQ3 2022: 144 institutionsQ4 2022: 221 institutionsQ1 2023: 220 institutionsQ2 2023: 2 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $1.98M
Q1 2021: $425.7MQ2 2021: $585.6MQ3 2021: $573.2MQ4 2021: $1.01BQ1 2022: $1.04BQ2 2022: $869.7MQ3 2022: $1.94BQ4 2022: $4.19BQ1 2023: $4.35BQ2 2023: $1.98MQ3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RXDX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20232$1.98M
Q1 2023220$4.35B
Q4 2022221$4.19B
Q3 2022144$1.94B
Q2 2022116$869.7M
Q1 2022103$1.04B
Q4 202174$1.01B
Q3 202151$573.2M
Q2 202149$585.6M
Q1 202141$425.7M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Prometheus Biosciences, Inc.; share changes are against Q1 2023.

Institutions holding RXDX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
TCI Wealth Advisors, Inc.0$00.00%−126−100.0%Sold out
Stone House Investment Management, LLC0$00.00%−100−100.0%Sold out
Covestor Ltd0$00.00%−72−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−73−100.0%Sold out
Allworth Financial LP0$00.00%−66−100.0%Sold out
Ellevest, Inc.0$00.00%−59−100.0%Sold out
Walleye Trading LLC0$00.00%−58−100.0%Sold out
Oliver Lagore Vanvalin Investment Group0$00.00%−47−100.0%Sold out
Private Trust Co NA0$00.00%−37−100.0%Sold out
Cutler Group LP0$00.00%−30−100.0%Sold out
Bell Investment Advisors, Inc0$00.00%−14−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−12−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−10−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−5−100.0%Sold out
Advisory Services Network, LLC0$00.00%−8−100.0%Sold out
Bogart Wealth, LLC0$00.00%−7−100.0%Sold out
Farther Finance Advisors, LLC0$00.00%−6−100.0%Sold out
True Wealth Design, LLC0$00.00%−1−100.0%Sold out
Signaturefd, LLC0$00.00%−1−100.0%Sold out
Harvest Group Wealth Management, LLC––––Not filed